Puscas D, Paun I, Ursea R, Lenghel N, Dinga C A
G E N. 1975 Jul-Dec;30(1-2):93-100.
The authors present the results of treatment with acetazolamide of gastroduodenal ulcer (356 gastric ulcer, 1.250 duodenal ulcers--859 with craters--, 24 pyloric stenosi with functional components, and 42 postgastrectomy peptic ulcers). The acetazolamide was administed in daily dosis of 25-30 mg/kg of body weight, sodium and potassium salts were added, and the liquid intake was increased (approx. 2 1 daily). A control was kept of the clinical, secretory, radiological, enzymological, and hydrolectrolytical modification. A decrease is observed of the in the carbonic anhidrase of the gastric mucosa and of the gastric secretion. There is also an increase in the gastric protection factors and a disappearance of ulcer pain. There are no significant hydroelectrolytic modifications of the blood. From a radiogical point of view, the crater of the postoperative gastric, pyloric and peptic ulcer disappears after 2 weeks of treatment, and in duodenal ulcers in 89% of the cases in 3 weeks. The method is the same time a quick, simple, an efficient therapeutic test for the differentiation of the gastric craters. The drug is well tolerated. Nevertheless a clinical, secretory and radiological control of the patients is necessary taking into account the counter-indication for the administration of acetazolamide.
作者介绍了用乙酰唑胺治疗胃十二指肠溃疡(356例胃溃疡、1250例十二指肠溃疡——其中859例有溃疡龛影——、24例伴有功能性成分的幽门狭窄以及42例胃切除术后消化性溃疡)的结果。乙酰唑胺的给药剂量为每日25 - 30毫克/千克体重,同时添加钠盐和钾盐,并增加液体摄入量(约每日2升)。对临床、分泌、放射、酶学及水电解质方面的变化进行了监测。观察到胃黏膜碳酸酐酶及胃分泌减少。胃保护因子增加,溃疡疼痛消失。血液中水电解质无明显变化。从放射学角度看,术后胃溃疡、幽门溃疡及消化性溃疡的溃疡龛影在治疗2周后消失,十二指肠溃疡在3周内89%的病例溃疡龛影消失。该方法同时也是一种快速、简单且有效的鉴别胃溃疡龛影的治疗性试验。该药物耐受性良好。然而,鉴于乙酰唑胺给药的禁忌证,对患者进行临床、分泌及放射学监测是必要的。